News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
743,040 Results
Type
Article (45345)
Company Profile (475)
Press Release (697207)
Multimedia
Podcasts (124)
Webinars (20)
Section
Business (209802)
Career Advice (2079)
Deals (36223)
Drug Delivery (120)
Drug Development (84323)
Employer Resources (175)
FDA (16842)
Job Trends (15267)
News (355434)
Policy (33537)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2680)
Accelerated approval (37)
Adcomms (28)
Allergies (148)
Alliances (51243)
ALS (179)
Alzheimer's disease (1739)
Antibody-drug conjugate (ADC) (335)
Approvals (17081)
Artificial intelligence (555)
Autoimmune disease (167)
Automation (42)
Bankruptcy (373)
Best Places to Work (11893)
BIOSECURE Act (20)
Biosimilars (197)
Biotechnology (331)
Bladder cancer (165)
Brain cancer (61)
Breast cancer (661)
Cancer (5009)
Cardiovascular disease (427)
Career advice (1758)
Career pathing (38)
CAR-T (295)
CDC (48)
Celiac Disease (2)
Cell therapy (791)
Cervical cancer (36)
Clinical research (71817)
Collaboration (1827)
Company closure (4)
Compensation (1195)
Complete response letters (67)
COVID-19 (2781)
CRISPR (102)
C-suite (907)
Cystic fibrosis (154)
Data (6410)
Decentralized trials (2)
Denatured (40)
Depression (148)
Diabetes (512)
Diagnostics (6787)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (273)
Drug pricing (197)
Drug shortages (29)
Duchenne muscular dystrophy (248)
Earnings (91642)
Editorial (61)
Employer branding (21)
Employer resources (154)
Events (121488)
Executive appointments (1019)
FDA (20042)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1553)
Gene editing (218)
Generative AI (46)
Gene therapy (654)
GLP-1 (1018)
Government (4790)
Grass and pollen (6)
Guidances (385)
Healthcare (19350)
HIV (64)
Huntington's disease (47)
IgA nephropathy (89)
Immunology and inflammation (280)
Immuno-oncology (66)
Indications (119)
Infectious disease (3064)
Inflammatory bowel disease (205)
Inflation Reduction Act (17)
Influenza (122)
Intellectual property (260)
Interviews (322)
IPO (16954)
IRA (53)
Job creations (3736)
Job search strategy (1465)
JPM (66)
Kidney cancer (16)
Labor market (87)
Layoffs (587)
Leadership (34)
Legal (8114)
Liver cancer (93)
Longevity (15)
Lung cancer (677)
Lymphoma (388)
Machine learning (43)
Management (59)
Manufacturing (829)
MASH (172)
Medical device (14058)
Medtech (14114)
Mergers & acquisitions (20356)
Metabolic disorders (1335)
Multiple sclerosis (170)
NASH (19)
Neurodegenerative disease (347)
Neuropsychiatric disorders (99)
Neuroscience (3058)
Neurotech (1)
NextGen: Class of 2026 (6837)
Non-profit (4613)
Now hiring (68)
Obesity (640)
Opinion (296)
Ovarian cancer (169)
Pain (220)
Pancreatic cancer (237)
Parkinson's disease (301)
Partnered (34)
Patents (513)
Patient recruitment (514)
Peanut (58)
People (60517)
Pharmaceutical (86)
Pharmacy benefit managers (30)
Phase 1 (22548)
Phase 2 (31621)
Phase 3 (23418)
Pipeline (5527)
Policy (305)
Postmarket research (2659)
Preclinical (9647)
Press Release (68)
Prostate cancer (250)
Psychedelics (56)
Radiopharmaceuticals (303)
Rare diseases (916)
Real estate (6086)
Recruiting (72)
Regulatory (25245)
Reports (53)
Research institute (2508)
Resumes & cover letters (362)
Rett syndrome (27)
RNA editing (21)
RSV (81)
Schizophrenia (156)
Series A (257)
Series B (204)
Service/supplier (11)
Sickle cell disease (105)
Special edition (27)
Spinal muscular atrophy (162)
Sponsored (43)
Startups (3827)
State (2)
Stomach cancer (19)
Supply chain (107)
Tariffs (87)
The Weekly (82)
Vaccines (1054)
Venture capital (96)
Weight loss (413)
Women's health (96)
Worklife (19)
Date
Today (144)
Last 7 days (586)
Last 30 days (2409)
Last 365 days (30776)
2026 (4120)
2025 (31117)
2024 (36366)
2023 (41078)
2022 (52358)
2021 (56867)
2020 (55071)
2019 (47705)
2018 (35931)
2017 (33192)
2016 (32641)
2015 (38646)
2014 (32376)
2013 (27350)
2012 (29456)
2011 (30117)
2010 (28254)
Location
Africa (771)
Alabama (90)
Alaska (7)
Arizona (323)
Arkansas (14)
Asia (40991)
Australia (6844)
California (11636)
Canada (3350)
China (1147)
Colorado (490)
Connecticut (505)
Delaware (344)
Europe (90257)
Florida (1723)
Georgia (366)
Hawaii (3)
Idaho (61)
Illinois (898)
India (70)
Indiana (533)
Iowa (24)
Japan (444)
Kansas (131)
Kentucky (42)
Louisiana (27)
Maine (72)
Maryland (1422)
Massachusetts (8445)
Michigan (330)
Minnesota (646)
Mississippi (5)
Missouri (130)
Montana (34)
Nebraska (28)
Nevada (122)
New Hampshire (84)
New Jersey (3096)
New Mexico (31)
New York (3052)
North Carolina (1554)
North Dakota (9)
Northern California (5672)
Ohio (342)
Oklahoma (21)
Oregon (46)
Pennsylvania (2334)
Puerto Rico (24)
Rhode Island (49)
South America (1139)
South Carolina (67)
South Dakota (1)
Southern California (4516)
Tennessee (178)
Texas (1788)
United States (41404)
Utah (347)
Vermont (1)
Virginia (273)
Washington D.C. (82)
Washington State (966)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
743,040 Results for "pain therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nocion Therapeutics to Present Preclinical Data Supporting Nocions™ as a Novel Approach for the Treatment of Pain at the Non-Opioid Pain Therapeutics Summit
January 27, 2026
·
3 min read
Press Releases
Dogwood Therapeutics, Inc. Chief Medical Officer, Dr. Michael Gendreau, to Present an Overview of the Halneuron® Pain Research Program at the 19th Annual Pain Therapeutics Summit
October 8, 2025
·
4 min read
Pain
Lilly Refines Pain Pipeline Again, Scrapping Mid-Stage Program
Before being discontinued, the P2X7 receptor blocker had cleared a master protocol study in chronic pain, though Eli Lilly said that results were not sufficient for advancement of the Asahi Kasei–partnered asset.
October 31, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit
February 1, 2026
·
12 min read
Press Releases
Dogwood Therapeutics Announces Positive Interim Phase 2b Clinical Trial Results in Chemotherapy Induced Neuropathic Pain
December 23, 2025
·
5 min read
Press Releases
Lexicon Pharmaceuticals Presents Additional Pilavapadin Data in Diabetic Peripheral Neuropathic Pain at 19th Annual Pain Therapeutics Summit
October 15, 2025
·
3 min read
Venture capital
Ambros Launches With $125M To Bring Italian Non-Opioid Pain Drug to America
Ambros Therapeutics’ non-opioid bisphosphonate analgesic, already approved in Italy, will soon begin a pivotal test in the U.S.
December 16, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Soin Neuroscience and Lilac Biosciences Launch Collaboration to Study RNA Signatures in Pain and Neuromodulation
February 13, 2026
·
3 min read
Press Releases
FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel-L, Confirms 12-Month Reduction in Back Pain Supports Product Efficacy
January 19, 2026
·
9 min read
Press Releases
NEXTBIOMEDICAL Secures Health Canada Approval for Nexsphere-F™ in Musculoskeletal Pain Embolization
January 30, 2026
·
3 min read
1 of 74,304
Next
